scispace - formally typeset
D

David H.K. Chui

Researcher at Boston University

Publications -  242
Citations -  9047

David H.K. Chui is an academic researcher from Boston University. The author has contributed to research in topics: Thalassemia & Fetal hemoglobin. The author has an hindex of 45, co-authored 240 publications receiving 8465 citations. Previous affiliations of David H.K. Chui include Hamilton Health Sciences & Columbia University.

Papers
More filters
Journal ArticleDOI

HbVar: A relational database of human hemoglobin variants and thalassemia mutations at the globin gene server.

TL;DR: A relational database of hemoglobin variants and thalassemia mutations, called HbVar, is constructed, which can be accessed on the web at http://globin.cse.psu.edu, and should be useful for clinical diagnosis as well as in fundamental studies ofhemoglobin biochemistry, globin gene regulation, and human sequence variation at these loci.
Journal ArticleDOI

Fetal hemoglobin in sickle cell anemia

TL;DR: New efforts to induce high HbF levels in sickle cell disease beyond those achievable with the current limited repertory of Hbf inducers are spurred on.
Journal ArticleDOI

Improvements in the hbvar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies

TL;DR: The frequencies for a large number of mutations causing beta-thalassemia in at-risk populations have been extracted from the published literature and made available for the user to query upon in HbVar.
Journal ArticleDOI

Hemoglobin H disease: not necessarily a benign disorder

TL;DR: The hemoglobin molecule is a tetramer consisting of 2 pairs of globin chains, each of which contains a heme group, which is located on the α-globin gene cluster.
Journal ArticleDOI

Prenatal exclusion of β thalassaemia major by examination of maternal plasma

TL;DR: The discovery of the presence of fetal DMA in maternal plasma has provided a new approach for non-invasive prenatal diagnosis of p thalassaemia and this work designed allele-specific primers and a fluorescent probe for detection of the codon 41/42 mutation in the β globin gene from maternal plasma by real-time PCR.